Your browser doesn't support javascript.
loading
Coiled-coil heterodimer-based recruitment of an exonuclease to CRISPR/Cas for enhanced gene editing.
Lainscek, Dusko; Forstneric, Vida; Mikolic, Veronika; Malensek, Spela; Pecan, Peter; Bencina, Mojca; Sever, Matjaz; Podgornik, Helena; Jerala, Roman.
Afiliação
  • Lainscek D; Department of Synthetic Biology and Immunology, National Institute of Chemistry, Hajdrihova 19, Ljubljana, 1000, Slovenia.
  • Forstneric V; EN-FIST Centre of Excellence, Trg Osvobodilne fronte 13, Ljubljana, 1000, Slovenia.
  • Mikolic V; Department of Synthetic Biology and Immunology, National Institute of Chemistry, Hajdrihova 19, Ljubljana, 1000, Slovenia.
  • Malensek S; Department of Hematology, Division of Internal Medicine, University Medical Centre Ljubljana, Zaloska 7, Ljubljana, 1000, Slovenia.
  • Pecan P; Graduate School of Biomedicine, University of Ljubljana, Ljubljana, 1000, Slovenia.
  • Bencina M; Department of Synthetic Biology and Immunology, National Institute of Chemistry, Hajdrihova 19, Ljubljana, 1000, Slovenia.
  • Sever M; Graduate School of Biomedicine, University of Ljubljana, Ljubljana, 1000, Slovenia.
  • Podgornik H; Department of Synthetic Biology and Immunology, National Institute of Chemistry, Hajdrihova 19, Ljubljana, 1000, Slovenia.
  • Jerala R; Graduate School of Biomedicine, University of Ljubljana, Ljubljana, 1000, Slovenia.
Nat Commun ; 13(1): 3604, 2022 06 23.
Article em En | MEDLINE | ID: mdl-35739111
ABSTRACT
The CRISPR/Cas system has emerged as a powerful and versatile genome engineering tool, revolutionizing biological and biomedical sciences, where an improvement of efficiency could have a strong impact. Here we present a strategy to enhance gene editing based on the concerted action of Cas9 and an exonuclease. Non-covalent recruitment of exonuclease to Cas9/gRNA complex via genetically encoded coiled-coil based domains, termed CCExo, recruited the exonuclease to the cleavage site and robustly increased gene knock-out due to progressive DNA strand recession at the cleavage site, causing decreased re-ligation of the nonedited DNA. CCExo exhibited increased deletion size and enhanced gene inactivation efficiency in the context of several DNA targets, gRNA selection, Cas variants, tested cell lines and type of delivery. Targeting a sequence-specific oncogenic chromosomal translocation using CCExo in cells of chronic myelogenous leukemia patients and in an animal model led to the reduction or elimination of cancer, establishing it as a highly specific tool for treating CML and potentially other appropriate diseases with genetic etiology.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sistemas CRISPR-Cas / Edição de Genes Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Eslovênia

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sistemas CRISPR-Cas / Edição de Genes Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Eslovênia